The Effect on Prognosis of Postoperative CA 19-9 Level in Patients With Pancreatic Cancer

被引：1
|
作者：
Kilickap, Saadettin [1 ]
Arslan, Cagatay [1 ]
机构：
[1] Hacettepe Univ, Inst Oncol, Dept Med Oncol, Ankara, Turkey
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2010年 / 33卷 / 03期
关键词：
RECURRENCE; ADENOCARCINOMA; SURVIVAL;
D O I：
10.1097/COC.0b013e31819fe1ff
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [31] The impact of CA 19-9 on survival in patients with clinical stage I pancreatic cancer
    Melucci, Alexa D.
    Chacon, Alexander C.
    Burchard, Paul R.
    Ullman, Nicholas A.
    Tsagkalidis, Vasleios
    Casabianca, Anthony S.
    Reitz, Alexandra
    Swift, David A.
    Goyal, Subir
    Switchenko, Jeffrey M.
    Carpizo, Darren R.
    Shah, Mihir Maheshkumar
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [32] Diagnostic Value of CA 19-9 in Patients with Pancreatic Cancer and Nonspecific Gastrointestinal Symptoms
    Safi F.
    Schlosser W.
    Kolb G.
    Beger H.G.
    Journal of Gastrointestinal Surgery, 1997, 1 (2) : 106 - 112
  • [33] Impact of CA 19-9 on Survival in Patients with Clinical Stage I Pancreatic Cancer
    Melucci, Alexa D.
    Chacon, Alexander C.
    Burchard, Paul R.
    Ullman, Nicholas A.
    Tsagkalidis, Vasleios
    Casabianca, Anthony S.
    Reitz, Alexandra C.
    Swift, David A.
    Goyal, Subir
    Switchenko, Jeffrey
    Carpizo, Darren R.
    Shah, Mihir M.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 445 - 446
  • [34] Exploring the role of CA 19-9 level as a predictor of survival in patients with advanced pancreatic adenocarcinoma
    Bekaii-Saab, T.
    Majumber, A.
    Trolli, E.
    Thomas, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 391 - 391
  • [35] CA 19-9 and pancreatic carcinoma, a revival?
    Ducreux, Michel
    Boige, Valerie
    Malka, David
    ONKOLOGIE, 2007, 30 (1-2): : 12 - 13
  • [36] Levels of tumor markers CEA/CA 19-9 in serum and peritoneal lavage predict postoperative recurrence in patients with pancreatic cancer
    Hata, Tatsuo
    Chiba, Kazuharu
    Mizuma, Masamichi
    Masuda, Kunihiro
    Ohtsuka, Hideo
    Nakagawa, Kei
    Morikawa, Takanori
    Hayashi, Hiroki
    Motoi, Fuyuhiko
    Unno, Michiaki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2022, 6 (06): : 862 - 872
  • [37] CA 19-9 IN PANCREATIC CANCER: RETROSPECTIVE EVALUATION OF 20 YEARS
    Molina, V.
    Visa, L.
    Conill, C.
    Navarro, S.
    Escudero, J. M.
    Auge, J. M.
    Filella, X.
    Fernandez Cruz, L.
    Ferrer, J.
    Molina, R.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1996 - 1996
  • [38] Prognostic value of CA 19-9 serum course in pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    HEPATO-GASTROENTEROLOGY, 1998, 45 (19) : 253 - 259
  • [39] CA 19-9 in evaluating the response to chemotherapy in advanced pancreatic cancer
    Ishii, H
    Okada, S
    Sato, T
    Wakasugi, H
    Saisho, H
    Furuse, J
    Ishikawa, O
    Matsuno, S
    Yokoyama, S
    HEPATO-GASTROENTEROLOGY, 1997, 44 (13) : 279 - 283
  • [40] EVALUATION OF CA 19-9 LEVELS AS A MARKER FOR PANCREATIC-CANCER
    SHAW, NY
    HUTTON, JM
    DALBOW, MH
    SWANSON, PA
    BORDEN, KK
    CLINICAL CHEMISTRY, 1987, 33 (06) : 1034 - 1034
12345